Research Shows GPs are Switched on to EPS

New research from doctors.net.uk has revealed that GPs' use of electronic prescriptions is gaining momentum. An online survey of 834 GPs in England found that 15% of respondents had already switched to EPS R2, with 25% of those not currently using electronic prescriptions planning to upgrade in 2014.

The research, conducted on behalf of NHS-contracted mail order pharmacy Pharmacy2U, is the first to present a comprehensive view of the EPS landscape in England.

It showed that many GPs have faith in an electronic future. Forty-three per cent of respondents - including those who have not yet switched - were confident that EPS would enable them to provide a more efficient repeat prescription service.

Confusion over patient choice
But the research also revealed confusion among GPs around the introduction of greater patient choice of pharmacy - a key element of EPS R2, as digital scripts remove the need for patients to take a paper copy to the pharmacy.

Almost half of the GPs surveyed (48%) admitted they did not know enough about the nominations process to explain it to patients. And 46% did not know that under EPS, patients have the freedom to nominate any EPS-enabled pharmacy, anywhere in England.

Despite this confusion, 56% agreed that greater choice of pharmacy was valuable because it allowed patients to find the most convenient option for them.

Teething troubles
The research also explored the practical issues involved in switching to digital prescriptions; 58% of GPs using EPS had experienced teething troubles when switching. Issues included lack of preparation among local pharmacies (55%) lack of DM&D coding (29%) and lack of training for practice staff (37%).

Dr Julian Harrison, a director of Pharmacy2U said: "It's encouraging to see the increased uptake of electronic prescriptions but concerning that a key element of the service - greater patient choice of pharmacy - is not yet fully understood by the profession."

Dr Donya Young, an early adopter of electronic prescriptions, is confident about the efficiency benefits of EPS R2. She said: "It is hard to see any negatives with EPS R2 once you address the initial preparation and staff training. The patients love being able to choose their most convenient pharmacy - wherever and whoever that may be. It has really helped our staff to improve efficiency at the practice, and being able to communicate speedily and accurately with our pharmacy colleagues has to be better and safer for all concerned."

In November 2013, MedeConnect, the research division of doctors.net.uk, surveyed 834 UK-registered GPs working in England to test understanding of different elements of EPS R2

Established in 1999, Pharmacy2U is the UK#s largest dedicated internet and mail order pharmacy. The company provides a free NHS mail order repeat prescription service. The service is enabled for EPS R2, making it an option for any patient whose GP uses electronic prescriptions.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...